Eli Lilly And Boehringer-Ingelheim Join Forces With The IDF To Learn More About Type 2 Diabetes
Early and comprehensive management of Type 2 Diabetes leads to better outcomes and fewer diabetes-related complications in people living with this disease, and conversations with the primary care physician from diagnosis forward are critical in achieving these results. This is the basis for a new, multi-national survey to investigate the conversations of physicians and people living with T2D, to determine their effect on treatment and outcomes. This survey, the largest of its kind, is the result of a partnership among pharmaceutical giants Eli Lilly and Company and Boehringer-Ingelheim, and the International Diabetes Foundation (IDF).
“Being diagnosed with Type 2 Diabetes can be a challenging and emotional period, which understandably, many people find overwhelming. Ensuring individuals have the support they need at this time as well as an understanding of the progressive nature of their condition and the importance of self-management - right from the start - is crucial to success in the long run. The early conversations people with Type 2 Diabetes have with their physicians are essential” said Ms. Anne Belton, Vice President at the International Diabetes Federation. “This new survey will provide valuable insights into these important early conversations and will help aid the development of solutions for physicians and people with Type 2 Diabetes. Together these will help deliver valuable support early on in the treatment pathway.” The study will examine the early conversations and perceptions of both T2D patients and their primary care physicians, with specific focus on challenges or areas for improvement. The survey data will be used by the Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance to develop solutions aimed at supporting both patients and physicians in their efforts to manage this condition. Early results are expected to be announced in 2014.
The survey is concentrated on the needs and realities of primary care. It employs a combination of both standard and new research approaches to investigate the early conversations in T2D. The information gained is expected to teach researchers at the Alliance more about how these conversations impact patient well-being and other self-reported outcomes. Subsequently, these results will provide insights to aid the development of solutions that can support physicians in conducting early T2D conversations and maximize the limited time they have for patients, by focusing on the elements that have the potential to make a difference.
Source: Business Wire